HRTS vs ZJAN
Tema Heart & Health ETF vs Innovator Equity Defined Protection ETF - 1 Yr January
Which is better, HRTS or ZJAN?
HRTS has been ahead.
HRTS has a lower expense ratio. HRTS led over 1Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | HRTS | ZJAN |
|---|---|---|
| Expense Ratio | 0.75%Best | 0.79% |
| AUM | $53M | $109M |
| Dividend Yield | 1.30% | 0.00% |
| Holdings | 92 | 15 |
| YTD Return | +2.75% | +3.98%Best |
| 1Y Return | +14.59%Best | +5.91% |
| 3Y Return (annualized) | +13.00% | - |
| Volatility (annualized) | 14.1% | 2.4%Best |
| Max Drawdown | -15.1% | -3.2%Best |
| $10,000 over 1.8 years | $12,660Best | $11,130 |
| Fund Family | Tema Global Limited | Innovator ETFs Trust |
| Category | Equity | Equity |
| Style | Large Cap Blend | Large Cap Blend |
| Inception | Nov 20, 2023 | Jan 2, 2025 |
Not shown on this pair: 5Y Return (annualized), Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 1.8 years row, are measured over the window both funds cover: Jan 2, 2025 to Oct 14, 2026 (1.8 years).
HRTS vs ZJAN growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 1.8 years both funds cover.
HRTS vs ZJAN Performance
Tema Heart & Health ETF (HRTS) is an ETF from Tema Global Limited and Innovator Equity Defined Protection ETF - 1 Yr January (ZJAN) is an ETF from Innovator ETFs Trust. Over the past year HRTS returned +14.59% while ZJAN returned +5.91%. Year to date, HRTS is up 2.75% versus a gain of 3.98% for ZJAN.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
HRTS has been the more volatile fund, with annualized monthly volatility of 14.1% compared with 2.4% for ZJAN. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -15.1% for HRTS and -3.2% for ZJAN. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.31. They move together some of the time, and apart the rest.
Fees and Cost Over Time
HRTS charges 0.75% per year while ZJAN charges 0.79%. On a $10,000 position that is $75 vs $79 annually, a gap of $4 per year that compounds over a long holding period. On income, HRTS currently yields 1.30% against 0.00% for ZJAN.
You are not choosing between two funds in isolation.
Whichever of HRTS and ZJAN you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, HRTS or ZJAN?
HRTS has an expense ratio of 0.75% while ZJAN charges 0.79%. HRTS is the cheaper option, by $4 a year on a $10,000 investment.
Which performed better, HRTS or ZJAN?
Over the past year HRTS returned +14.59% vs +5.91% for ZJAN, so HRTS leads on 1-year performance. Over the longest common window we track (2 years), HRTS annualized +14.00% vs +6.13% for ZJAN. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, HRTS or ZJAN?
HRTS has been the more volatile fund at 14.1% annualized versus 2.4% for ZJAN. Worst drawdown: HRTS -15.1% vs ZJAN -3.2%.
Should I hold both HRTS and ZJAN?
HRTS and ZJAN have a monthly-return correlation of 0.31, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, HRTS or ZJAN?
HRTS yields 1.30% while ZJAN yields 0.00%, so HRTS currently pays the higher dividend yield.
Is ZJAN better than HRTS?
HRTS has a lower expense ratio. HRTS led over 1Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.